[Growth Factors and Interleukins in Amniotic Membrane Tissue Homogenate]

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Biochemistry

Context:

• Therapy-resistant corneal epithelial defects pose a significant clinical challenge.
• Amniotic membrane preparations are explored for their regenerative potential in ocular surface diseases.
• Understanding the biochemical composition of amniotic membrane homogenates is crucial for therapeutic development.

Purpose:

• To quantify the concentrations of key growth factors and cytokines in amniotic membrane homogenates.
• To investigate the presence of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), interleukin-6 (IL-6), and interleukin-8 (IL-8).
• To compare the efficacy of cell-lysis buffer versus phosphate-buffered saline (PBS) in preparing homogenates for analysis.

Summary:

• Enzyme-linked immunosorbent assay (ELISA) was used to analyze amniotic membrane homogenates from 8 placentas.
• Epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF) were detected.
• Keratinocyte growth factor (KGF), interleukin-6 (IL-6), and interleukin-8 (IL-8) were below detection limits.
• Hepatocyte growth factor (HGF) levels were significantly higher in PBS-prepared homogenates compared to cell-lysis buffer.

Impact:

• Amniotic membrane homogenates contain growth factors (EGF, bFGF, HGF) beneficial for corneal healing.
• The absence of inflammatory cytokines (IL-6, IL-8) suggests a favorable safety profile.
• These findings support the potential of amniotic membrane homogenate eye drops as a novel therapeutic for refractory corneal epithelial defects.